✦ LIBER ✦

Encouraging Results with Inolimomab (Anti-IL-2 Receptor) as Treatment for Refractory Acute Graft-versus-Host Disease

✍ Scribed by Jose Luis Piñana; David Valcárcel; Rodrigo Martino; M. Estela Moreno; Anna Sureda; Javier Briones; Salut Brunet; Jorge Sierra

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Updated Experience with Inolimomab as Tr

✍ García-Cadenas, Irene; Valcárcel, David; Martino, Rodrigo; Piñana, Jose Luis; No 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 207 KB

TREATMENT OF ACUTE GRAFT-VERSUS-HOST DIS

✍ HERVE, P 📂 Article 📅 1988 🏛 The Lancet 🌐 English ⚖ 354 KB

Therapy for refractory acute graft versu

✍ V.A. Moreira; C.M. Bonfim; M.A. Bitencourt; D.C. Setubal; C. Lorenzato; J. Ruiz; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Therapy for severe refractory acute graf

✍ Funke, V A M; de Medeiros, C R; Setúbal, D C; Ruiz, J; Bitencourt, M A; Bonfim, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Effective Use of Tociluzimab, an Anti-In

✍ Kolb, Michelle; Madina, Gay-Gaddi; Bhatia, Monica; Satwani, Prakash 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 112 KB